Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance - Investor's Business Daily

The company issued lackluster earnings outlooks for the second quarter and full year.

You are being redirected to the original discussion. Please continue if you want to read the full post.

Continue to original article

You will be redirected in 3 seconds.